Articles:

RL Talbert

The pharmacist's perspective on newer thrombolytic therapies for acute myocardial infarction.Introduction
Am J Health Syst Pharm 1997 54: 3-4. [PDF]  

JM Kessler

Decision analysis in the formulary process
Am J Health Syst Pharm 1997 54: 5-8. [Abstract] [PDF]  

RL Talbert

Strategies for the management of acute myocardial infarction: selecting patients for thrombolytic therapy
Am J Health Syst Pharm 1997 54: 9-16. [Abstract] [PDF]  

RW Smalling

A fresh look at the molecular pharmacology of plasminogen activators: from theory to test tube to clinical outcomes
Am J Health Syst Pharm 1997 54: 17-22. [Abstract] [PDF]  

KA Stringer

Clinical trials in thrombolytic therapy, Part 1: Outcome markers that go beyond mortality reduction
Am J Health Syst Pharm 1997 54: 23-26. [Abstract] [PDF]  

LM Lopez

Clinical trials in thrombolytic therapy, Part 2: The open-artery hypothesis and RAPID-1 and RAPID-2
Am J Health Syst Pharm 1997 54: 27-30. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.